Geron Corp. (GERN)
0.8707
-0.04
(-4.63%)
USD |
NASDAQ |
Nov 20, 16:00
0.8696
0.00 (0.00%)
After-Hours: 20:00
Geron Shareholders Equity (Quarterly) : 226.70M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 226.70M |
| June 30, 2026 | 218.61M |
| March 31, 2026 | 229.11M |
| December 31, 2025 | 225.87M |
| September 30, 2025 | 248.71M |
| June 30, 2025 | 259.53M |
| March 31, 2025 | 268.24M |
| December 31, 2024 | 280.32M |
| September 30, 2024 | 292.28M |
| June 30, 2024 | 306.70M |
| March 31, 2024 | 344.87M |
| December 31, 2023 | 247.95M |
| September 30, 2023 | 290.61M |
| June 30, 2023 | 298.43M |
| March 31, 2023 | 326.06M |
| December 31, 2022 | 80.00M |
| September 30, 2022 | 108.17M |
| June 30, 2022 | 142.05M |
| March 31, 2022 | 97.49M |
| December 31, 2021 | 126.42M |
| September 30, 2021 | 151.55M |
| June 30, 2021 | 176.21M |
| March 31, 2021 | 201.16M |
| December 31, 2020 | 210.95M |
| September 30, 2020 | 232.83M |
| Date | Value |
|---|---|
| June 30, 2020 | 250.68M |
| March 31, 2020 | 120.81M |
| December 31, 2019 | 135.16M |
| September 30, 2019 | 152.39M |
| June 30, 2019 | 157.04M |
| March 31, 2019 | 169.41M |
| December 31, 2018 | 177.73M |
| September 30, 2018 | 183.47M |
| June 30, 2018 | 178.36M |
| March 31, 2018 | 101.13M |
| December 31, 2017 | 103.80M |
| September 30, 2017 | 108.27M |
| June 30, 2017 | 113.01M |
| March 31, 2017 | 117.25M |
| December 31, 2016 | 122.38M |
| September 30, 2016 | 128.91M |
| June 30, 2016 | 130.30M |
| March 31, 2016 | 136.48M |
| December 31, 2015 | 142.13M |
| September 30, 2015 | 147.89M |
| June 30, 2015 | 118.36M |
| March 31, 2015 | 125.18M |
| December 31, 2014 | 130.71M |
| September 30, 2014 | 137.18M |
| June 30, 2014 | 144.58M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -105.37M |
| Amgen, Inc. | 14.35B |
| Anika Therapeutics, Inc. | 137.58M |
| BioCryst Pharmaceuticals, Inc. | -397.38M |
| Imunon, Inc. | 2.622M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 527.11M |
| Total Liabilities (Quarterly) | 300.41M |
| Debt to Equity Ratio | 1.104 |
| Current Ratio | 6.313 |
| Net Debt Paydown Yield | -0.01% |